TD Asset Management’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $36.2M | Sell |
1,470,258
-126,255
| -8% | -$2.92M | 0.03% | 377 |
|
|
2026
Q1 | $38.2M | Sell |
1,596,513
-5,938
| -0.4% | -$145K | 0.03% | 375 |
|
|
2025
Q4 | $36.3M | Buy |
1,602,451
+516,628
| +48% | +$11.2M | 0.03% | 380 |
|
|
2025
Q3 | $21.9M | Buy |
1,085,823
+806,682
| +289% | +$13.5M | 0.02% | 488 |
|
|
2025
Q2 | $3.99M | Buy |
279,141
+135,748
| +95% | +$1.59M | ﹤0.01% | 797 |
|
|
2025
Q1 | $1.51M | Sell |
143,393
-62,942
| -31% | -$712K | ﹤0.01% | 1020 |
|
|
2024
Q4 | $2.5M | Sell |
206,335
-220,066
| -52% | -$2.88M | ﹤0.01% | 945 |
|
|
2024
Q3 | $6.11M | Buy |
426,401
+47,059
| +12% | +$656K | 0.01% | 754 |
|
|
2024
Q2 | $5.47M | Buy |
379,342
+45,203
| +14% | +$722K | 0.01% | 745 |
|
|
2024
Q1 | $5.44M | Buy |
334,139
+2,554
| +0.8% | +$39.9K | 0.01% | 757 |
|
|
2023
Q4 | $4.94M | Buy |
331,585
+56,266
| +20% | +$637K | ﹤0.01% | 771 |
|
|
2023
Q3 | $3.09M | Buy |
275,319
+53,129
| +24% | +$617K | ﹤0.01% | 838 |
|
|
2023
Q2 | $2.24M | Sell |
222,190
-33,988
| -13% | -$315K | ﹤0.01% | 941 |
|
|
2023
Q1 | $2.41M | Buy |
256,178
+124,796
| +95% | +$1.47M | ﹤0.01% | 928 |
|
|
2022
Q4 | $1.61M | Sell |
131,382
-7,217
| -5% | -$90K | ﹤0.01% | 1047 |
|
|
2022
Q3 | $1.75M | Sell |
138,599
-426,605
| -75% | -$7.46M | ﹤0.01% | 1041 |
|
|
2022
Q2 | $11.1M | Sell |
565,204
-503,377
| -47% | -$11.9M | 0.01% | 572 |
|
|
2022
Q1 | $27.9M | Sell |
1,068,581
-179,849
| -14% | -$4.79M | 0.03% | 406 |
|
|
2021
Q4 | $35.4M | Buy |
1,248,430
+434,540
| +53% | +$13.5M | 0.03% | 382 |
|
|
2021
Q3 | $26M | Buy |
813,890
+1,950
| +0.2% | +$65.4K | 0.03% | 414 |
|
|
2021
Q2 | $29.6M | Buy |
811,940
+26,109
| +3% | +$861K | 0.03% | 393 |
|
|
2021
Q1 | $23.1M | Buy |
785,831
+86,704
| +12% | +$2.67M | 0.03% | 434 |
|
|
2020
Q4 | $21.4M | Sell |
699,127
-3,401
| -0.5% | -$104K | 0.03% | 423 |
|
|
2020
Q3 | $19.6M | Buy |
702,528
+41,119
| +6% | +$1.04M | 0.03% | 401 |
|
|
2020
Q2 | $14.2M | Buy |
661,409
+63,200
| +11% | +$1.4M | 0.02% | 438 |
|
|
2020
Q1 | $13.4M | Buy |
598,209
+42,800
| +8% | +$1.17M | 0.02% | 414 |
|
|
2019
Q4 | $16.4M | Sell |
555,409
-168,170
| -23% | -$4.57M | 0.02% | 424 |
|
|
2019
Q3 | $19.2M | Sell |
723,579
-139,468
| -16% | -$4.18M | 0.03% | 375 |
|
|
2019
Q2 | $29.2M | Buy |
863,047
+42,784
| +5% | +$1.39M | 0.04% | 306 |
|
|
2019
Q1 | $26.3M | Buy |
820,263
+631,439
| +334% | +$19.4M | 0.04% | 319 |
|
|
2018
Q4 | $5.95M | Buy |
188,824
+71,000
| +60% | +$2.32M | 0.01% | 611 |
|
|
2018
Q3 | $4.11M | Buy |
+117,824
| New | +$4.14M | 0.01% | 793 |
|
Other funds holding ELAN
VPM
VCM
BCIM
TD Asset Management's ELAN Position: Q2 2026 in Review
TD Asset Management reduced its Elanco Animal Health (ELAN) stake by 7.9% in Q2 2026, selling an estimated $2.92M and leaving 1,470,258 shares worth $36.2M. The position accounts for 0.03% of the portfolio, ranked #377.
TD Asset Management first reported a position in ELAN in Q3 2018 and has held it in 32 quarters since. The position peaked at $38.2M in Q1 2026. 409 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.
- TD Asset Management held 1,470,258 shares of Elanco Animal Health worth $36.2M as of Q2 2026.
- TD Asset Management sold 126,255 Elanco Animal Health shares in Q2 2026, an estimated $2.92M.
- Elanco Animal Health made up 0.03% of TD Asset Management's portfolio in Q2 2026, its #377 holding.
- TD Asset Management first reported a position in Elanco Animal Health in Q3 2018 and has held it in 32 quarters since.
- TD Asset Management's Elanco Animal Health position peaked at $38.2M in Q1 2026.
- 409 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.
Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.